David Cohn

David Cohn, MD


Make an Appointment

Overall Patient Satisfaction Rating

4.9 out of 5




I am a professor in the Department of Obstetrics and Gynecology at The Ohio State University College of Medicine, where I have been a faculty member since 2001. I was named to the Castle Connolly list of “Regional Top Doctors” from 2012-2019, as well as being rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016 and 2017.

I am the chief medical officer at The James Cancer Hospital as well as the director of Gynecologic Cancer Research and the associate director of the Gynecologic Oncology Fellowship Program at Ohio State. After graduating from the University of Michigan, I attended Georgetown University School of Medicine in Washington, D.C., and completed my residency in obstetrics and gynecology at the University of Washington Medical Center in Seattle. I completed my fellowship in gynecologic oncology at Washington University in St. Louis.

My interests include investigation of value-based cancer care delivery, and have an active research program into the genetics and genomics of endometrial cancer. Additionally, our laboratory investigates signaling in ovarian cancer with a focus on early biomarkers of the disease. I am the secretary-treasurer of the Society of Gynecologic Oncology and hold leadership positions in NRG Oncology.

Education and Background


Georgetown University School of Medicine

Washington, DC



Seattle, WA


OB/GYN / Gynecological Oncology

Washington University Hospital

St. Louis, MO

Board Certifications

American Board of OB/GYN

American Board of OB/GYN (Subspecialty: Gynecologic Oncology)

Academic Department

Department of Obstetrics & Gynecology

Division of Gynecologic Oncology

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 12/20/2018, Dr. Cohn has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.


Oncology Analytics

Journals | Elsevier


Patient Satisfaction Review

The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.

Overall Ratings (out of 209 reviews)
4.9 out of 5
Kept you informed about your condition and treatment

4.9/ 5

Amount of time spent with you

4.8/ 5

Concern for your questions and issues

4.9/ 5

Skill and knowledge

4.9/ 5

Overall quality of care

4.9/ 5

Patient Comments (3 total comments)

Reviewed: 5/1/2019

Dr. Cohn is caring, wise, and compassionate.

Reviewed: 4/25/2019

All the individuals associated with the Stephanie Spielman Breast Center location have always made my visits & treatments comfortable. All my questions are always answered & I am always encouraged to call Dr. Cohn's office with any concerns & I have taken advantage of this connection many times.

Reviewed: 3/4/2019

They always treat me with courtesy and kindness.


Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer.

Han S, Dwivedi P, Mangrio FA, Dwivedi M, Khatik R, Cohn DE, Si T, Xu RX

Artif Cells Nanomed Biotechnol 47


Inhibition of miR-328-3p impairs cancer stem cell function and prevents metastasis in ovarian cancer.

Srivastava AK, Banerjee A, Cui T, Han C, Cai S, Liu L, Wu D, Cui R, Li Z, Zhang X, Xie G, Selvendiran K, Patnaik S, Karpf AR, Liu J, Cohn DE, Wang QE

Cancer Res in press


Related Videos

Care Philosophy video
Symptoms, detection and treatment of ovarian cancer
Why you should Choose The James
Back to Find a Doctor Search

Make an Appointment


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Please enter a keyword (i.e. Name, Location) or choose a Cancer Type